Amylin Pharmaceuticals (AMLN) Eli Lilly & Co. (LLY) and Alkermes Inc. (ALKS) announced after the close Tuesday that the FDA issued a complete response letter regarding the New Drug Application for BYDUREON. The FDA requested a thorough QT study with exposures of exenatide higher than typical therapeutic levels of BYDUREON.
Amylin Pharmaceuticals gapped open dramatically lower Wednesday, but recovered some ground in the second half of the morning. Shares finished down by 9.46 at $11.03 on the highest volume of the year. The stock sank to an 11 1/2 month low.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.